| Current Price | $26.17 | Mkt Cap | $3.8B |
|---|---|---|---|
| Open | $26.49 | P/E Ratio | -4.99 |
| Prev. Close | $26.17 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $25.75 - $26.52 | Volume | 841,706 |
| 52-Wk Range | $16.04 - $27.59 | Avg. Daily Vol. | 1,292,407 |
Insmed Incorporated, a biopharmaceutical company, is focused on developing and commercializing novel, targeted inhalation therapies.
| Current Price | $26.17 | Mkt Cap | $3.8B |
|---|---|---|---|
| Open | $26.49 | P/E Ratio | -4.99 |
| Prev. Close | $26.17 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $25.75 - $26.52 | Volume | 841,706 |
| 52-Wk Range | $16.04 - $27.59 | Avg. Daily Vol. | 1,292,407 |
The best Bull and Bear pitches based on recency and number of recommendations.
High Volume Breakout on 02/12/13
Voraciously consuming an inordinate amount of cash relative to its revenues. Long term prospects had better pan out, because the near term looks pretty dismal. And besides, downwithpumpers provided the tip.
Read the most recent pitches from players about INSM.
Recs
scrubs62074
(< 20)
Submitted: 2/12/2013 2:56:15 PM :
Start Price:
$6.07
NASDAQ:INSM Score:
+146.32
High Volume Breakout on 02/12/13
Recs
solanZRaider
(75.65)
Submitted: 6/26/2012 4:07:27 PM :
Start Price:
$3.18
NASDAQ:INSM Score:
+494.46
ZZ Top
Recs
nvcrader
(43.06)
Submitted: 1/21/2012 2:49:47 AM :
Start Price:
$5.03
NASDAQ:INSM Score:
+190.80
UPDATE 2-FDA lifts hold on Insmed's lung disease drug, shares jump
Find the members with the highest scoring picks in INSM.
hayrettin (72.48) Score: +513.19
The Score Leader is the player with the highest score across all their picks in INSM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| hayrettin | 72.48 | 8/20/2012 |
|
5Y | $3.16 | +724.68% | +203.33% | +521.36 | 0 Comment | |
| solanZRaider | 75.65 | 6/27/2012 |
|
1Y | $3.18 | +719.50% | +225.04% | +494.46 | 1 Comment | |
| popatop100 | 31.79 | 7/17/2012 |
|
5Y | $3.63 | +617.91% | +218.12% | +399.78 | 0 Comment | |
| JustinTheFool | 83.41 | 5/19/2009 |
|
5Y | $16.79 | +55.21% | +374.48% | +319.27 | 0 Comment | |
| wpson | < 20 | 8/22/2011 |
|
3M | $3.93 | +563.10% | +273.73% | +289.38 | 0 Comment | |
| BlueInsight | < 20 | 8/5/2011 |
|
5Y | $4.22 | +517.54% | +253.50% | +264.04 | 0 Comment | |
| craigliles | < 20 | 9/14/2011 |
|
5Y | $4.29 | +507.46% | +265.13% | +242.33 | 0 Comment | |
| nvcrader | 43.06 |
|
|
5Y | $5.03 | +418.09% | +227.29% | +190.80 | 1 Comment | |
| MFGramps | 27.16 | 8/3/2011 |
|
3Y | $5.03 | +418.09% | +245.36% | +172.73 | 0 Comment | |
| Nappingrabbit | 39.39 | 8/4/2011 |
|
5Y | $5.04 | +417.06% | +245.94% | +171.12 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
